Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LESAKA TECHNOLOGIES INCLSAK · Entity 5691 | Director · Executive | December 31, 2024 | January 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LESAKA TECHNOLOGIES INC
Report date December 31, 2024 · Filed January 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2029-01-31 | Direct | 350,000 |
Reported balance
After 2024-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-12-31 · Grant · Acquired 350,000 · Balance 350,000 F1: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. |
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.00 · Expires 2029-01-31 | Direct | 250,000 |
Reported balance
After 2024-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-12-31 · Grant · Acquired 250,000 · Balance 250,000 F1: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. |
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.00 · Expires 2029-01-31 | Direct | 350,000 |
Reported balance
After 2025-01-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-01-02 · Grant · Acquired 100,000 · Balance 350,000 F1: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. |
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-01-31 | Direct | 150,000 |
Reported balance
After 2025-01-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-01-02 · Grant · Acquired 150,000 · Balance 150,000 F1: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. |
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2029-01-31 | Direct | 150,000 |
Reported balance
After 2025-01-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-01-02 · Grant · Acquired 150,000 · Balance 150,000 F1: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2025 Filed Jan 2, 2025 21:05 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000016 · form4.xml · derivative · entry 5 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2029-01-31 F1 · derivative.exercise_date: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 21:05 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000016 · form4.xml · derivative · entry 4 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2029-01-31 F1 · derivative.exercise_date: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 21:05 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantEmployee stock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000016 · form4.xml · derivative · entry 3 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common stock · 100,000 shares Expires 2029-01-31 F1 · derivative.exercise_date: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:05 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantEmployee stock option (right to buy) · Derivative | 250,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000016 · form4.xml · derivative · entry 2 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common stock · 250,000 shares Expires 2029-01-31 F1 · derivative.exercise_date: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:05 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantEmployee stock option (right to buy) · Derivative | 350,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000016 · form4.xml · derivative · entry 1 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common stock · 350,000 shares Expires 2029-01-31 F1 · derivative.exercise_date: The stock options will vest on December 31, 2026, provided that the Reporting Person maintains continuous employment with the Company through such date. The stock options may only be exercised from December 31, 2026 to January 31, 2029. Read SEC document |
| October 25, 2023 Filed Oct 27, 2023 20:06 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-019761 · form4.xml · nonDerivative · entry 1 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 F1 · shares: Represents a grant of restricted stock approved by the remuneration committee of the Issuer's board of directors pursuant to the Amended and Restated 2022 Stock Incentive Plan. The shares vest on June 30, 2025, and vesting is subject to the Reporting Person's continuous employment with the Company or serving on the Issuer's board of directors through June 30, 2025. If the Reporting Person's employment is terminated by the Company without cause then the shares of restricted stock will continue to vest on June 30, 2025, notwithstanding the fact that the Reporting Person is no longer an employee of the Issuer. If the Reporting Person's employment is terminated for cause, then any unvested shares will be forfeited. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:10 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000255 · form4.xml · nonDerivative · entry 2 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,000 F2 · shares: Represents a grant of restricted stock approved by the remuneration committee of the Issuer's board of directors pursuant to the Amended and Restated 2022 Stock Incentive Plan. The shares vest on June 30, 2024, and vesting is subject to the Reporting Person's continuous employment with the Company or serving on the Issuer's board of directors through June 30, 2024. If the Reporting Person's employment is terminated by the Company without cause then the shares of restricted stock will continue to vest on June 30, 2024, notwithstanding the fact that the Reporting Person is no longer an employee of the Issuer. If the Reporting Person's employment is terminated for cause, then any unvested shares will be forfeited. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:10 UTC | LESAKA TECHNOLOGIES INC LSAK · Entity 5691 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000255 · form4.xml · nonDerivative · entry 1 Heilbron Steven John · CIK 0001929776 · Director · Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 F1 · shares: Represents a grant of restricted stock approved by the remuneration committee of the Issuer's board of directors pursuant to the Amended and Restated 2022 Stock Incentive Plan. The shares vested in full on the grant date. The Reporting Person has undertaken to not sell or otherwise dispose of the shares until December 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.